ACR 2010 criteria for fibromyalgia critiqued

Both the American College of Rheumatology 2010 criteria for diagnosing fibromyalgia and its modified version had “unsatisfactory” sensitivity and specificity in identifying the disorder in the...

Field of Interest: Rheumatology
Type: News Item

Psoriasiform lesions linked to anti-TNF treatment

VIENNA – Patients treated with an anti–tumor necrosis factor drug had a 5% annual rate of developing one or more psoriasiform skin lesions in a review of more than 400 patients who received these...

Field of Interest: Dermatology
Type: News Item

Psoriasiform lesions linked to anti-TNF treatment

VIENNA – Patients treated with an anti–tumor necrosis factor drug had a 5% annual rate of developing one or more psoriasiform skin lesions in a review of more than 400 patients who received these...

Field of Interest: Gastroentero...
Type: News Item

Secukinumab showed sustained efficacy in psoriasis

AMSTERDAM – The investigational biologic agent secukinumab continued to show strong efficacy through 52 weeks of treatment in a new secondary analysis of the pivotal phase III ERASURE trial. For...

Field of Interest: Dermatology
Type: News Item

In psoriasis, is pushing for PASI 90 really worthwhile?

AMSTERDAM – Does pushing for a PASI 90 response instead of settling for a PASI 75 matter to patients being treated for moderate-to-severe chronic plaque psoriasis? You bet it does, Dr. Mark G....

Field of Interest: Dermatology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness